In last trading session, Macrogenics Inc (NASDAQ:MGNX) saw 0.62 million shares changing hands with its beta currently measuring 2.18. Company’s recent per share price level of $15.67 trading at $0.45 or 2.96% at ring of the bell on the day assigns it a market valuation of $980.32M. That closing price of MGNX’s stock is at a discount of -39.63% from its 52-week high price of $21.88 and is indicating a premium of 72.62% from its 52-week low price of $4.29. Taking a look at company’s average trading volume volume of 1.49 million if we extend that period to 3-months.

Macrogenics Inc (NASDAQ:MGNX) trade information

Upright in the green during last session for gaining 2.96%, in the last five days MGNX remained trading in the green while hitting it’s week-highest on Wednesday, 05/01/24 when the stock touched $15.67 price level, adding 3.87% to its value on the day. Macrogenics Inc’s shares saw a change of 62.89% in year-to-date performance and have moved 7.62% in past 5-day. Macrogenics Inc (NASDAQ:MGNX) showed a performance of -11.87% in past 30-days.

Macrogenics Inc (MGNX) estimates and forecasts

Statistics highlight that Macrogenics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 196.22% of value to its shares in past 6 months, showing an annual growth rate of -29.81% while that of industry is 18.50. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 48.88% during past 5 years.

MGNX Dividends

Macrogenics Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.